NCT07416188 2026-04-22Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Not yet recruiting40 enrolled
NCT07539441 2026-04-20A Study of Mirdametinib in People With Central Nervous System TumorsMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting26 enrolled
NCT03157128 2026-04-16LIBRETTO-001Eli Lilly and CompanyPhase 1/2 Active not recruiting857 enrolled 24 charts 6 FDA
NCT05278208 2026-04-13Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsNationwide Children's HospitalPhase 1/2 Recruiting65 enrolled
NCT04774718 2026-04-06A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsHoffmann-La RochePhase 1/2 Recruiting42 enrolled